At the one-month follow-up, the SBK and FS-LASIK groups showed comparable surgical satisfaction scores of 98.08. Three years later, the scores were 97.09 for SBK and 97.10 for FS-LASIK, respectively, with all P-values exceeding 0.05.
At both one month and three years following surgery, SBK and FS-LASIK procedures displayed comparable corneal aberration profiles and patient satisfaction scores.
Comparing SBK and FS-LASIK procedures, no variation was seen in corneal aberrations or patient satisfaction at one month and three years.
A consideration of the ramifications of transepithelial corneal collagen crosslinking (CXL) in addressing corneal ectasia that occurs following laser-assisted in situ keratomileusis (LASIK).
In 16 patients, with 18 eyes each, CXL surgery was performed. Among these patients, 9 had additional LASIK flap lift procedures. Light with a wavelength of 365 nm and a power density of 30 mW/cm² was used for CXL.
Treatment protocols included either a four-minute pulsed laser, or a transepithelial flap-on procedure, (n=9 eyes; 365 nm, 3 mW/cm^2).
The 30-minute method was performed. A postoperative analysis of maximum keratometry (Kmax), anterior elevation, posterior elevation, spherical equivalent (SE), logMAR uncorrected distance visual acuity (UDVA), aberrations, and central corneal thickness (CCT) was conducted at the 12-month mark.
In this investigation, eighteen eyes were observed across sixteen patients (eleven male, five female). Computational biology Compared to flap-lift CXL, Kmax flattening showed a greater extent after flap-on CXL, demonstrating statistical significance (P = 0.014). Endothelial cell density and posterior elevation displayed a steady and unchanging trend throughout the observation period. Measurements taken 12 months after flap-on CXL demonstrated a statistically significant decrease (P < 0.05) in vertical asymmetry index (IVA), keratoconus index (KI), and central keratoconus index (CKI). The flap-off CXL group showed no statistically significant changes. Twelve months post-flap-lift CXL, a statistically significant (P < 0.05) decrease in spherical aberrations and total root mean square was found.
Post-LASIK keratectasia disease progression was effectively halted through the use of transepithelial collagen crosslinking in our investigation. Our recommendation for these patients is the utilization of the flap-on surgical method.
Our study successfully utilized transepithelial collagen crosslinking to prevent the worsening of post-LASIK keratectasia. We advise the utilization of the flap-on surgical procedure for these instances.
To investigate the beneficial and adverse effects of accelerated cross-linking (CXL) in the pediatric population.
A longitudinal study examining progressive keratoconus (KC) in patients below the age of eighteen. Sixty-four eyes in thirty-nine cases had the accelerated CXL protocol performed on them with the epithelium removed. Detailed examination notes encompassed visual acuity (VA), slit-lamp findings, refractive error, pentacam keratometry (K) readings, corneal thickness measurements, and the precise location of the thinnest corneal pachymetry. At days one, five, and one, the cases were given further attention.
, 3
, 6
Following the twelfth month post-procedure, please return this item.
Substantial and statistically significant improvement in the average values for VA, K, and mean corneal astigmatism was documented (p < 0.00001). The Kmax reading, initially measured at 555-564 diopters (D), decreased to 544-551 diopters (D) after 12 months of accelerated CXL. This change followed a pre-operative range of 474-704 D and a post-operative range of 46-683 D. Two cases showed a pattern of advancement. In the course of the process, sterile infiltrate and persistent haze were encountered as complications.
Pediatric KC finds accelerated CXL to be both effective and efficacious.
Accelerated CXL therapy exhibits a potent and demonstrably positive impact on pediatric keratoconus, proving its efficacy and effectiveness.
With an artificial intelligence (AI) model as its instrument, this study investigated and analyzed the clinical and ocular surface risk factors influencing the development of keratoconus (KC).
In this prospective study, 450 keratoconus (KC) patients were analyzed. We applied the random forest (RF) classifier, derived from a previous study on the longitudinal assessment of tomographic parameters (designed to predict progression and its absence), to classify these patients. To evaluate clinical and ocular surface risk factors, a questionnaire was employed, encompassing reported eye rubbing, duration of indoor activity, use of lubricants and immunomodulator topical medications, computer use duration, hormonal disturbances, hand sanitizer use, immunoglobulin E (IgE) levels, and vitamin D and B12 levels from blood analyses. An AI model was subsequently constructed to evaluate if these risk factors correlated with the future advancement or lack thereof of KC progression. Metrics such as the area under the curve (AUC), and others, were evaluated for analysis.
The tomographic AI model's classification yielded 322 eyes categorized as progressing, and 128 eyes classified as not progressing. 76% of the cases, characterized by tomographic changes and classified as progressive, were accurately predicted to exhibit progression based on clinical risk factors observed at the initial visit. In terms of information gain, IgE demonstrated the most prominent result, followed by the presence of systemic allergies, vitamin D levels, and the practice of rubbing the eyes. Rural medical education Clinical risk factors were assessed by an AI model, achieving an AUC of 0.812.
Utilizing AI for patient risk stratification and profiling, considering clinical factors, was demonstrated in this study as essential for impacting the progression of KC eyes and enabling improved management strategies.
This research emphasizes the importance of utilizing artificial intelligence in assessing patient risk and developing profiles, particularly in the context of keratoconus (KC) progression and optimizing care.
This research project undertakes an analysis of keratoplasty follow-up protocols and the factors contributing to follow-up attrition at a tertiary eye care institution.
This single-center, cross-sectional study was conducted retrospectively. The study encompassed corneal transplantation procedures on 165 eyes. Data collection encompassed recipient demographic characteristics, keratoplasty motivations, visual acuity recordings before and after the surgery, duration of follow-up observation, and graft status at the final follow-up examination. An essential goal was to evaluate the causative factors behind the attrition of graft recipients. Postoperative follow-up non-adherence, defined as LTFU, encompassed missed appointments occurring at intervals of four visits at two weeks, three visits at one month, six visits at one month, twelve visits at two months, eighteen visits at two months, twenty-four visits at three months, and thirty-six visits at six months. The ultimate aim of the secondary outcome was to scrutinize best-corrected visual acuity (BCVA) within the patient cohort present for the definitive follow-up.
The follow-up response rates among recipients, measured at 6, 12, 18, 24, and 36 months, were 685%, 576%, 479%, 424%, and 352%, respectively. Geographic remoteness from the central location and the age of the patients were notable factors in lost follow-up. To complete the follow-up process, the occurrence of failed grafts needing transplantation, and those undertaking penetrating keratoplasty for visual aims were determinative factors.
The persistence of difficulties in the follow-up process for corneal transplant patients is a significant concern. In the delivery of follow-up care, special consideration should be given to elderly patients and those in remote communities.
A frequent hurdle in corneal transplantation is the difficulty in subsequent follow-up care. Elderly patients and those residing in remote locations should be given priority for subsequent medical evaluations.
Study of the outcomes of penetrating keratoplasty (PK) in patients with Pythium insidiosum keratitis, following anti-Pythium therapy (APT) using linezolid and azithromycin.
During the period from May 2016 to December 2019, a retrospective review was carried out, concentrating on the medical records of patients who suffered from P. insidiosum keratitis. https://www.selleckchem.com/products/colivelin.html Patients who experienced at least two weeks of APT treatment and who were subsequently subjected to TPK were part of the studied group. Detailed data regarding demographic characteristics, clinical presentations, microbial findings, intraoperative procedures, and postoperative outcomes were meticulously recorded.
Of the 238 cases of Pythium keratitis observed during the study period, 50 met the required inclusion criteria and were thus incorporated into the study. The geometric mean of the infiltrate sample had a median of 56 mm, exhibiting an interquartile range between 40 and 72 mm. Patients' topical APT treatment, lasting a median of 35 days (interquartile range 25-56), preceded their scheduled surgery. In the context of TPK, worsening keratitis proved to be the most frequent indicator, affecting 82% (41) of the 50 cases observed. No evidence of infection recurrence was seen. Of the 50 eyes examined, 49 (98%) displayed a stable anatomical globe. After 24 months, half of the grafts had been lost. Ten eyes (20%) displayed a pronounced graft, reaching a median visual acuity of 20/125 after a median follow-up of 184 months (interquartile range 11-26 months). A clear graft was found to be significantly associated with a graft size under 10 mm, as evidenced by statistical significance (P = 0.002) of this observation (5824, CI1292-416).
Good anatomical outcomes are associated with TPK procedures undertaken after APT administration. A <10 mm graft was more likely to survive.
The implementation of TPK after the administration of APT usually leads to positive anatomical results. Grafts that were smaller, under 10mm, had a significantly greater probability of graft survival.
A comprehensive analysis of the visual consequences and complications of Descemet stripping endothelial keratoplasty (DSEK), including their management, for 256 eyes treated at a tertiary care eye hospital in the southern Indian region.